EVH
Evolent Health, Inc. NYSE Listed Jun 5, 2015$4.49
-3.85%
vs $4.67
Mkt Cap $512.8M
52w Low $2.17
24.1% of range
52w High $11.79
50d MA $3.80
200d MA $4.66
P/E (TTM)
-0.9x
EV/EBITDA
—
P/B
1.2x
Debt/Equity
2.4x
ROE
-103.4%
P/FCF
107.8x
RSI (14)
59.80
ATR (14)
$0.34
Beta
0.37
50d MA
$3.80
200d MA
$4.66
Avg Volume
2.7M
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
800 North Glebe Road · Arlington, VA 22203 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 3.83 | -4.4% | +11.5% | -2.1% | -5.3% | +5.1% | -0.7% | — |
| Feb 24, 2026 | AMC | 0.06 | 0.08 | +33.3% | 2.56 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% | — |
| Nov 6, 2025 | AMC | 0.10 | 0.05 | -50.0% | 6.00 | +3.0% | -17.3% | -0.2% | +1.8% | -11.7% | -6.5% | — |
| Aug 7, 2025 | AMC | 0.09 | -0.10 | -211.1% | 9.69 | -13.4% | -7.1% | +2.4% | -4.6% | +1.9% | -1.7% | — |
| May 8, 2025 | AMC | 0.09 | 0.06 | -33.3% | 10.78 | +3.9% | -16.0% | +2.9% | -0.4% | -3.6% | -1.3% | — |
| Feb 20, 2025 | AMC | 0.38 | -0.02 | -105.3% | 10.71 | -0.2% | -2.6% | -2.4% | +2.8% | -9.7% | -8.1% | — |
| Nov 7, 2024 | AMC | 0.30 | 0.04 | -86.7% | 24.57 | -41.4% | -45.6% | +13.2% | -4.6% | -11.7% | -0.6% | — |
| Aug 8, 2024 | AMC | 0.21 | 0.30 | +42.9% | 20.87 | +32.3% | +26.5% | -4.2% | +3.8% | +1.5% | +2.1% | — |
| May 9, 2024 | AMC | 0.21 | 0.34 | +61.9% | 26.96 | -2.7% | -9.3% | -2.9% | +0.4% | -1.3% | -1.0% | — |
| Feb 22, 2024 | AMC | 0.11 | 0.23 | +109.1% | 29.77 | +10.0% | +14.4% | -1.6% | +1.9% | -1.1% | +0.3% | — |
| Nov 2, 2023 | AMC | 0.09 | 0.30 | +233.3% | 24.01 | +6.7% | +13.5% | +3.3% | +1.0% | -1.9% | -0.8% | — |
| Aug 2, 2023 | AMC | 0.09 | 0.14 | +55.6% | 29.63 | -1.8% | -5.1% | +5.9% | -2.6% | -0.4% | -2.4% | — |
| May 3, 2023 | AMC | 0.15 | 0.21 | +40.0% | 35.20 | -9.1% | -4.7% | +1.4% | +2.1% | +1.3% | -0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.25 | $3.17 | -2.5% | +10.2% | -2.0% | +1.1% | -4.2% | -6.8% |
| Feb 26 | Truist | Maintains | Buy → Buy | — | $3.14 | $3.14 | +0.0% | +5.7% | -2.1% | +10.2% | -2.0% | +1.1% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $3.14 | $3.14 | +0.0% | +5.7% | -2.1% | +10.2% | -2.0% | +1.1% |
| Feb 26 | Citigroup | Maintains | Buy → Buy | — | $3.14 | $3.14 | +0.0% | +5.7% | -2.1% | +10.2% | -2.0% | +1.1% |
| Feb 25 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 25 | BTIG | Maintains | Buy → Buy | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 25 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $3.21 | $3.18 | -0.9% | +1.6% | -5.2% | -1.0% | -5.6% | -1.4% |
| Jan 9 | Citigroup | Maintains | Buy → Buy | — | $4.16 | $4.17 | +0.2% | +0.2% | -0.5% | -3.4% | -2.7% | +1.0% |
| Jan 6 | Citizens | Maintains | Market Outperform → Market Outperform | — | $3.95 | $3.93 | -0.5% | +1.8% | +3.2% | +0.2% | +0.2% | -0.5% |
| Nov 21 | Citigroup | Maintains | Buy → Buy | — | $3.69 | $3.67 | -0.5% | +12.2% | +3.1% | +0.9% | -2.6% | +0.0% |
| Nov 17 | JP Morgan | Maintains | Overweight → Overweight | — | $4.18 | $4.10 | -1.9% | -7.4% | +3.4% | -11.5% | +4.2% | +12.2% |
| Nov 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.16 | $4.03 | -3.1% | +0.5% | -7.4% | +3.4% | -11.5% | +4.2% |
| Nov 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $5.04 | $5.05 | +0.2% | -11.7% | -6.5% | +0.5% | -7.4% | +3.4% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $4.96 | $5.01 | +1.0% | -0.2% | +1.8% | -11.7% | -6.5% | +0.5% |
| Nov 10 | Citizens | Maintains | Market Outperform → Market Outperform | — | $4.96 | $5.01 | +1.0% | -0.2% | +1.8% | -11.7% | -6.5% | +0.5% |
| Nov 7 | BTIG | Maintains | Buy → Buy | — | $6.00 | $6.18 | +3.0% | -17.3% | -0.2% | +1.8% | -11.7% | -6.5% |
| Sep 30 | BTIG | Maintains | Buy → Buy | — | $8.77 | $8.76 | -0.1% | -3.5% | -5.1% | -1.7% | +4.3% | +0.2% |
| Sep 24 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $8.39 | $8.49 | +1.2% | +14.5% | -7.2% | +0.3% | -2.0% | -3.5% |
| Sep 9 | BTIG | Maintains | Buy → Buy | — | $9.67 | $9.82 | +1.6% | +3.3% | -8.0% | +1.3% | -3.1% | -4.4% |
| Sep 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.67 | $9.82 | +1.6% | +3.3% | -8.0% | +1.3% | -3.1% | -4.4% |
| Aug 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.62 | $9.91 | +3.0% | +0.2% | +0.1% | -0.4% | -0.3% | -0.9% |
| Jul 17 | Truist | Maintains | Buy → Buy | — | $11.44 | $11.71 | +2.4% | -1.5% | -15.4% | +2.4% | +0.1% | +4.5% |
| Jun 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $8.65 | $8.89 | +2.8% | +6.9% | +13.5% | +1.1% | +0.8% | +0.4% |
| May 13 | Needham | Maintains | Buy → Buy | — | $9.31 | $9.22 | -1.0% | -0.4% | -3.6% | -1.3% | +0.1% | -2.4% |
| May 9 | UBS | Maintains | Buy → Buy | — | $10.78 | $11.20 | +3.9% | -16.0% | +2.9% | -0.4% | -3.6% | -1.3% |
| Apr 28 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $8.98 | $9.04 | +0.7% | +4.0% | +5.4% | +0.2% | +0.9% | +7.4% |
| Apr 10 | Truist | Maintains | Buy → Buy | — | $10.00 | $9.83 | -1.7% | -1.1% | +1.4% | -2.4% | -5.1% | -0.6% |
| Mar 10 | JP Morgan | Maintains | Overweight → Overweight | — | $8.99 | $9.49 | +5.6% | +1.2% | +3.2% | +1.0% | +0.6% | -1.4% |
| Feb 24 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $10.43 | $10.44 | +0.1% | -2.4% | +2.8% | -9.7% | -8.1% | +3.6% |
| Feb 21 | Needham | Maintains | Buy → Buy | — | $10.71 | $10.69 | -0.2% | -2.6% | -2.4% | +2.8% | -9.7% | -8.1% |
| Feb 21 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.71 | $10.69 | -0.2% | -2.6% | -2.4% | +2.8% | -9.7% | -8.1% |
| Feb 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $9.97 | $10.02 | +0.5% | +0.5% | +1.0% | +4.0% | +1.8% | -2.6% |
| Feb 12 | Needham | Maintains | Buy → Buy | — | $9.86 | $9.66 | -2.0% | -2.6% | +3.9% | +0.5% | +1.0% | +4.0% |
| Jan 28 | JP Morgan | Maintains | Overweight → Overweight | — | $9.98 | $10.04 | +0.6% | +4.4% | -0.1% | +1.6% | -1.2% | -2.3% |
| Jan 24 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.18 | $9.97 | -2.1% | -0.8% | -1.2% | +4.4% | -0.1% | +1.6% |
| Jan 24 | Oppenheimer | Maintains | Outperform → Outperform | — | $10.18 | $9.97 | -2.1% | -0.8% | -1.2% | +4.4% | -0.1% | +1.6% |
| Jan 23 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.00 | $10.04 | +0.4% | +1.8% | -0.8% | -1.2% | +4.4% | -0.1% |
| Jan 22 | Truist | Maintains | Buy → Buy | — | $10.17 | $10.10 | -0.7% | -1.7% | +1.8% | -0.8% | -1.2% | +4.4% |
| Jan 21 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $10.00 | $10.04 | +0.4% | +1.7% | -1.7% | +1.8% | -0.8% | -1.2% |
| Jan 16 | UBS | Maintains | Buy → Buy | — | $9.97 | $9.96 | -0.1% | +1.9% | -1.6% | +1.7% | -1.7% | +1.8% |
| Jan 15 | Needham | Maintains | Buy → Buy | — | $11.18 | $11.40 | +2.0% | -10.8% | +1.9% | -1.6% | +1.7% | -1.7% |
| Jan 14 | RBC Capital | Maintains | Outperform → Outperform | — | $12.39 | $12.70 | +2.5% | -9.8% | -10.8% | +1.9% | -1.6% | +1.7% |
| Jan 13 | Truist | Maintains | Buy → Buy | — | $12.54 | $12.40 | -1.1% | -1.2% | -9.8% | -10.8% | +1.9% | -1.6% |
| Jan 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $12.60 | $12.41 | -1.5% | -0.5% | -1.2% | -9.8% | -10.8% | +1.9% |
| Jan 10 | Citigroup | Maintains | Buy → Buy | — | $12.60 | $12.41 | -1.5% | -0.5% | -1.2% | -9.8% | -10.8% | +1.9% |
| Nov 22 | JP Morgan | Maintains | Overweight → Overweight | — | $11.59 | $11.61 | +0.2% | -2.9% | +8.5% | +8.6% | -2.5% | -0.1% |
| Nov 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $12.38 | $12.26 | -1.0% | -0.2% | -3.2% | -5.4% | +2.5% | -2.9% |
| Nov 13 | Citigroup | Maintains | Buy → Buy | — | $14.44 | $14.53 | +0.6% | -11.7% | -0.6% | -2.3% | -0.2% | -3.2% |
No insider trades available.
8-K
Evolent Health, Inc. -- 8-K Filing
Jun 4
8-K · 2.02
!! High
Evolent Health, Inc. -- 8-K 2.02: Earnings Results
Evolent Health reported Q1 2026 earnings results on May 7, 2026, which investors can review in the attached press release for details on operational performance and financial condition.
May 7
8-K
Evolent Health, Inc -- 8-K Filing
Evolent Health reported Q4 2025 results, showing the company's performance in managing complex healthcare conditions through its simplified care delivery model.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 18,556,246 | $74M | Added | Dec 2025 |
| 2 | Ubs Group Ag | 8,150,361 | $19M | Added | Mar 2026 |
| 3 | Engaged Capital | 5,563,912 | $13M | — | Mar 2026 |
| 4 | D.e. Shaw & Co | 5,434,032 | $12M | Added | Mar 2026 |
| 5 | Jane Street Group, Llc | 2,952,947 | $12M | Added | Dec 2025 |
| 6 | Vanguard Capital Management Llc | 4,867,403 | $11M | New | Mar 2026 |
| 7 | Maverick Capital Ltd | 2,572,763 | $6M | Added | Mar 2026 |
| 8 | Hudson Bay Capital Management Lp | 1,460,000 | $6M | Added | Dec 2025 |
| 9 | Tejara Capital Ltd | 1,946,650 | $4M | Added | Mar 2026 |
| 10 | Rock Point Advisors, Llc | 1,786,681 | $4M | Added | Mar 2026 |
| 11 | Hrt Financial Lp | 1,726,196 | $4M | Added | Mar 2026 |
| 12 | Citigroup Inc | 584,465 | $2M | Reduced | Dec 2025 |
| 13 | Vanguard Portfolio Management Llc | 930,878 | $2M | New | Mar 2026 |
| 14 | Northern Trust Corp | 917,137 | $2M | Reduced | Mar 2026 |
| 15 | Bnp Paribas Financial Markets | 891,403 | $2M | Added | Mar 2026 |
| 16 | Two Sigma Investments, Lp | 871,493 | $2M | Reduced | Mar 2026 |
| 17 | Marshall Wace, Llp | 785,012 | $2M | Added | Mar 2026 |
| 18 | Citadel Advisors Llc | 705,222 | $2M | Reduced | Mar 2026 |
| 19 | Capitolis Liquid Global Markets Llc | 630,000 | $1M | — | Mar 2026 |
| 20 | Qube Research & Technologies Ltd | 557,830 | $1M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$512.8M
Enterprise Value
$1.33B
P/E (TTM)
-0.89x
Forward P/E
32.70x
PEG Ratio
-0.00x
P/B
1.24x
P/S
0.27x
P/FCF
107.84x
EV/EBITDA
—
Shares Out
114.2M
Financials (TTM)
Revenue
$1.88B
Net Income
-$534.5M
EBITDA
-$361.3M
Free Cash Flow
$4.8M
Op Cash Flow
$38.8M
EPS Basic
$-5.07
EPS Diluted
$-5.07
EPS Forward
$0.14
Gross Margin
15.1%
Op Margin
-0.2%
Net Margin
-28.5%
Balance Sheet
Total Assets
$1.90B
Total Liab.
$1.48B
Total Equity
$415.2M
Cash
$151.9M
LT Debt
$970.5M
Book Value/Sh
$3.64
Debt/Equity
2.38x
Current Ratio
1.31
Quick Ratio
1.31
Returns & Growth
ROE
-103.4%
ROA
-22.6%
ROIC
-0.3%
Rev Growth YoY
-26.6%
EPS Growth YoY
-525.9%
Price Returns
2W
-3.7%
1M
+5.3%
3M
+21.5%
6M
-6.0%
12M
-47.0%
Technicals
52W High
$11.79
52W Low
$2.17
50d MA
$3.80
200d MA
$4.66
RSI (14)
59.80
ATR (14)
$0.34
Beta
0.37
Avg Volume
2.7M
Dividends
Div Rate
$0.10
Div Yield
2.6%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.38
High
$10.00
Low
$3.50
Median
$6.00
Data updated apr 25, 2026 7:59am
· Source: financialmodelingprep.com